Method for producing spiramycin by replacing fermentation raw material with shikimic acid bacterial residue produced by escherichia coli fermentation and product
By replacing the nitrogen source and growth factor in the spiramycin fermentation culture medium with shiizuic acid fermentation bacteria residue, the problem of high cost of shiizuic acid fermentation residue treatment and spiramycin raw materials is solved, and cost reduction and product quality improvement are achieved, which is significantly improved. The economic and environmental benefits of the enterprise.
Patent Information
- Application Number
- CN202411392771.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-08
- Publication Date
- 2024-12-06
AI Technical Summary
In the prior art, the bacterial residue produced by shikimic acid fermentation is high in cost, resulting in high environmental pressure and limited economic benefits, and the spiromycin fermentation raw materials are expensive, affecting the economic benefits of the enterprise.
Shikimic acid fermentation bacteria residue is used to replace the nitrogen source and growth factor in the spiromycin fermentation medium. After filtration through ceramic membrane, it is used as the raw material for spiromycin fermentation, reducing production costs and improving product quality.
The production cost of spiromycin fermentation was reduced by 27.76%, the product titer was increased by 9.1%, the problem of high cost of bacterial residue treatment and raw material was solved, and the economic and environmental benefits of the enterprise were improved.
Smart Images

Figure BDA0005072894010000061 
Figure BDA0005072894010000071 
Figure BDA0005072894010000081
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of spiramycin production, and specifically relates to a method and product for producing spiramycin by using shikimic acid bacteria residue produced by Escherichia coli fermentation to replace fermentation raw materials. Background Art
[0002] At present, the technology of producing shikimic acid by fermenting glucose and other raw materials with genetically engineered E. coli has been industrialized. However, the problem of solid waste disposal after extracting shikimic acid not only increases the cost of solid waste disposal, but also brings environmental pressure, which seriously affects the economic benefits of enterprises.
[0003] During the extraction process of shikimic acid after fermentation, wastewater containing a large amount of solid matrix is generated. After preliminary filtration, shikimic acid bacteria residue can be obtained, the main components of which include bacteria, unconsumed culture medium, metabolites produced during the fermentation process, degradation products of the culture medium, flocculants and acidifiers added during the extraction process, etc. These bacteria residues contain rich resources, such as bacteria, proteins, suspended solids, various inorganic salts, organic acids and reducing sugars.
[0004] In the prior art, the methods used by enterprises to process shikimic acid bacteria residue mainly include: (1) high-temperature incineration after making a cake through filter pressing; (2) extracting bacterial protein for the production of organic-inorganic compound fertilizer. However, these methods have certain limitations: (1) High-temperature incineration requires expensive equipment investment and operating costs, which increases the burden on enterprises. If the incineration is not thorough, it may also cause secondary environmental pollution. (2) The process of producing compound fertilizer is cumbersome. Although it can bring certain economic benefits, the processing cost is high, the economic benefit improvement is limited, and sometimes it is not worth the cost.
[0005] Therefore, it is an urgent problem for technical personnel in this field to seek new ways to treat shikimic acid bacteria residue to reduce the environmental pressure of enterprises and thus improve their economic benefits. Summary of the invention
[0006] The object of the present invention is to provide a method for producing spiramycin by using shikimic acid fermentation residue, specifically using shikimic acid fermentation residue to partially replace the nitrogen source and growth factor in the spiramycin fermentation medium, while reducing the production cost, it can also ensure that the product quality and yield of spiramycin are better than the existing fermentation formula. According to the actual measured data, compared with the original formula of spiramycin fermentation production, the technical solution provided by the present invention can reduce the raw material cost by 27.76%, and the titer of the obtained product is 9.1% higher than that of the control group.
[0007] The method can solve the problems of high cost of treating the residue produced after shikimic acid fermentation and solid waste pollution to the environment, and can also solve the problems of high cost of fermentation raw materials in spiramycin fermentation production. By adopting the technical solution provided by the present invention, the waste residue of shikimic acid fermentation is fully utilized, the production cost of spiramycin fermentation is greatly reduced, and the economic benefits of the enterprise are improved.
[0008] To achieve the above object, the present invention provides a method for producing spiramycin by using shikimic acid fermentation residue, comprising the following steps:
[0009] 1) preparing shikimic acid fermentation residue: filtering the waste liquid recovered from the production of shikimic acid, collecting the precipitate to obtain shikimic acid fermentation residue;
[0010] 2) Using the shikimic acid fermentation residue obtained in step 1) as a component of the fermentation medium to replace cottonseed protein and / or corn steep liquor for fermentation production of spiramycin.
[0011] In a preferred embodiment, in step 1), a ceramic membrane is used for filtration, and the filtration pore size is 20-50 nm. The present invention uses energy-saving and environmentally friendly ceramic membranes for filtration. Compared with traditional filter paper, ceramic membrane filtration can take into account both stability and high efficiency.
[0012] In a preferred embodiment, in the step 1), the prepared shikimic acid fermentation residue is tested: the total protein is ≥ 50%.
[0013] In a preferred embodiment, in step 2), the solution of replacing cottonseed protein and / or corn steep liquor with shikimic acid fermentation residue specifically comprises:
[0014] 50% of the cottonseed protein and 40% of the corn steep liquor are replaced by the same mass of shikimic acid fermentation residue; or, 80% of the cottonseed protein and 50% of the corn steep liquor are replaced by the same mass of shikimic acid fermentation residue; or, 100% of the cottonseed protein and 60% of the corn steep liquor are replaced by the same mass of shikimic acid fermentation residue.
[0015] In a preferred embodiment, in step 2), the components of the fermentation medium include the following components by weight: 86.4-129.6 parts by weight of dextrin, 2.22-3.32 parts by weight of yeast powder, 2.88-4.32 parts by weight of sodium nitrate, 0-23.06 parts by weight of cottonseed protein, 5.76-8.64 parts by weight of sodium chloride, 4.43-6.65 parts by weight of potassium chloride, 36-54 parts by weight of glucose, and 1.3-2.5 parts by weight of carbon. 14.76-22.14 weight parts of calcium carbonate, 21.60-32.4 weight parts of corn steep liquor, 2.88-4.32 weight parts of ammonium sulfate, 21.6-32.4 weight parts of soybean oil, 1.47-2.21 weight parts of magnesium sulfate, 0.29-0.43 weight parts of folate, 0.43-0.65 weight parts of cobalt chloride, 5.9-8.86 weight parts of potassium dihydrogen phosphate, and 44.66-78.52 weight parts of shikimic acid fermentation residue.
[0016] In a preferred embodiment, in the step 2), the components of the fermentation medium include the following components in parts by weight: 108 parts by weight of dextrin, 2.77 parts by weight of yeast powder, 3.6 parts by weight of sodium nitrate, 0-23.06 parts by weight of cottonseed protein, 7.2 parts by weight of sodium chloride, 5.54 parts by weight of potassium chloride, 45 parts by weight of glucose, 18.45 parts by weight of calcium carbonate, 21.60-32.4 parts by weight of corn steep liquor, 3.6 parts by weight of ammonium sulfate, 27 parts by weight of soybean oil, 1.85 parts by weight of magnesium sulfate, 0.36 parts by weight of folate, 0.54 parts by weight of cobalt chloride, 7.2 parts by weight of potassium dihydrogen phosphate, and 44.66-78.52 parts by weight of shikimic acid fermentation residue.
[0017] Another object of the present invention is to provide spiramycin prepared by any of the above methods.
[0018] Compared with the prior art, the technical solution of the present invention has the following advantages:
[0019] The fermentation residue of E. coli fermentation to produce shikimic acid is wastewater containing a large amount of solid matrix, with complex components, including bacteria, culture medium, metabolites and degradation products in the biological fermentation process, as well as inorganic acid liquid. The treatment steps are cumbersome, the environmental pressure is high, and a large amount of funds and reagents are required.
[0020] By adopting the technical solution provided by the present invention, after simple filtration treatment, it can be used as a nitrogen source and growth factor for spiramycin fermentation, replacing cottonseed protein and corn steep liquor. The technical solution of the present invention is a new way to recycle the shikimic acid bacteria residue, which can not only recover a large amount of useful substances, but also greatly reduce the concentration of wastewater generated in the production process, reduce the burden of sewage treatment in the next step, and achieve good environmental and social benefits. DETAILED DESCRIPTION
[0021] In order to enable those skilled in the art to better understand the present invention, the present invention is further described in detail below in conjunction with specific implementation methods, but it should be understood that the protection scope of the present invention is not limited by the specific implementation methods.
[0022] The embodiment of the present invention provides a method and product for producing spiramycin by using shikimic acid bacteria residue produced by Escherichia coli fermentation to replace fermentation raw materials, thereby solving the problem of treating shikimic acid bacteria residue in the prior art. While making full use of solid waste and reducing the production cost of spiramycin, it can also ensure that the product quality and output of spiramycin are better than those of existing fermentation formulas.
[0023] The technical solution of the present application is described in detail below through specific embodiments:
[0024] Unless otherwise specified, the technical means used in the present invention are conventional means well known to those skilled in the art, and the various raw materials, reagents, instruments and equipment used in the present invention can be purchased from the market or prepared by existing methods. The reagents used in the present invention are analytically pure unless otherwise specified. In the present invention, the waste liquid recovered from the production of shikimic acid comes from Tianfang Pharmaceutical Company, and the process is to produce shikimic acid by fermentation of Escherichia coli and produce waste liquid containing residues. In the present invention and the embodiments, the fermentation production method of spiramycin used is the prior art, and the specific route can be found in "Research on Optimization of Production Process of European Classic Spiramycin", Liu Yingbin, Northwest Agriculture and Forestry University. The main steps are as follows: 1. The cryotube is inoculated into the mother bottle at 26°C and cultured for 48h; 2. The mother bottle is transferred to the child bottle at 26°C and cultured for 18h; 3. The child bottle is inoculated into the seed tank at 27°C and cultured for 48h; 4. The seed tank is transferred to the secondary seed tank at 27°C and cultured for 20h; 4. The secondary seed tank is transferred to the fermentation tank at 27°C and fermented for 120h; 5. The fermentation is terminated and the fermentation liquid is placed in the downstream process, that is, the fermentation step is completed.
[0025] In the present invention, parts by weight may be μg, mg, g, kg or other weight units known in the art, or multiples thereof, such as 1 / 10, 1 / 100, 10 times, 100 times or the like.
[0026] Example 1
[0027] A method for producing spiramycin by using shikimic acid fermentation residue to replace fermentation raw materials, specifically comprising the following steps:
[0028] (1) Preparing shikimic acid fermentation residue: filtering wastewater after shikimic acid production with a ceramic membrane, and detecting that the total protein is ≥50%, thereby obtaining shikimic acid fermentation residue;
[0029] (2) The obtained shikimic acid fermentation residue is used as a component of the fermentation medium in the production of spiramycin fermentation, and at the same time partially replaces cottonseed protein and corn steep liquor as the fermentation raw materials for producing spiramycin; the weight (unit: kg) of each component of the fermentation medium used is as follows: dextrin 108, yeast powder 2.77, sodium nitrate 3.6, cottonseed protein 23.06, sodium chloride 7.2, potassium chloride 5.54, glucose 45, calcium carbonate 18.45, corn steep liquor 32.40, ammonium sulfate 3.6, soybean oil 27, magnesium sulfate 1.85, cobalt chloride 0.54, potassium dihydrogen phosphate 7.2, foetida 0.36, and shikimic acid residue 44.66.
[0030] In this embodiment, the same mass of shikimic acid fermentation residue replaced 50% of the amount of cottonseed protein and 40% of the amount of corn steep liquor. That is, before the addition of shikimic acid fermentation residue, the theoretical amount of cottonseed protein was 46.12, and the theoretical amount of corn steep liquor was 54, while in this embodiment, 23.06 of shikimic acid fermentation residue was added to replace 50% of the amount of cottonseed protein, and 21.6 of shikimic acid fermentation residue was added to replace 40% of the amount of corn steep liquor.
[0031] Example 2
[0032] A method for producing spiramycin by using shikimic acid fermentation residue to replace fermentation raw materials, specifically comprising the following steps:
[0033] (1) Preparing shikimic acid fermentation residue: filtering wastewater after shikimic acid production with a ceramic membrane, and detecting that the total protein is ≥50%, thereby obtaining shikimic acid fermentation residue;
[0034] (2) The obtained shikimic acid fermentation residue is used as a component of the fermentation medium in the production of spiramycin fermentation, and at the same time partially replaces cottonseed protein and corn steep liquor as the fermentation raw materials for producing spiramycin; the weight (unit: kg) of each component of the fermentation medium used is as follows: dextrin 108, yeast powder 2.77, sodium nitrate 3.6, cottonseed protein 9.22, sodium chloride 7.2, potassium chloride 5.54, glucose 45, calcium carbonate 18.45, corn steep liquor 27.00, ammonium sulfate 3.6, soybean oil 27, magnesium sulfate 1.85, cobalt chloride 0.54, potassium dihydrogen phosphate 7.2, folate 0.36, and shikimic acid residue 63.90.
[0035] In this embodiment, the shikimic acid fermentation residue replaced 80% of the cottonseed protein and 50% of the corn steep liquor with the same mass.
[0036] Example 3
[0037] A method for producing spiramycin by using shikimic acid fermentation residue to replace fermentation raw materials, specifically comprising the following steps:
[0038] (1) Preparing shikimic acid fermentation residue: filtering wastewater after shikimic acid production with a ceramic membrane, and detecting that the total protein is ≥50%, thereby obtaining shikimic acid fermentation residue;
[0039] (2) The obtained shikimic acid fermentation residue is used as a component of the fermentation medium in the production of spiramycin fermentation, and at the same time partially replaces cottonseed protein and corn steep liquor as the fermentation raw materials for producing spiramycin; the weight (unit: kg) of each component of the fermentation medium used is as follows: dextrin 108, yeast powder 2.77, sodium nitrate 3.6, cottonseed protein 0, sodium chloride 7.2, potassium chloride 5.54, glucose 45, calcium carbonate 18.45, corn steep liquor 21.6, ammonium sulfate 3.6, soybean oil 27, magnesium sulfate 1.85, cobalt chloride 0.54, potassium dihydrogen phosphate 7.2, folate 0.36, and shikimic acid residue 78.52.
[0040] In this embodiment, the shikimic acid fermentation residue replaced 100% of the cottonseed protein and 60% of the corn steep liquor with the same mass.
[0041] Effect Example 1
[0042] As a pharmaceutical manufacturer, based on the actual production cost of the product, the direct economic benefits of using shikimic acid fermentation residue to replace cottonseed protein and corn steep liquor in the fermentation raw materials for the fermentation production of spiramycin are shown in Table 1:
[0043] Table 1 Comparison of the cost of using shikimic acid fermentation residues to replace cottonseed protein and corn steep liquor in spiramycin fermentation medium
[0044]
[0045]
[0046] As can be seen from Table 1, the cost of raw materials for spiramycin fermentation is calculated based on the planned price in 2024. After the shikimic acid bacteria residue replaces 100% cottonseed protein and 60% corn steep liquor, the cost of the fermentation formula decreases by 27.76%. Although the above calculation does not take the residue and transportation costs into account, the environmental protection treatment cost of the residue is also not reduced. Moreover, in the same production enterprise, if the waste liquid generated by the production of shikimic acid is recycled and directly used in the production line of spiramycin, the transportation cost can be ignored. The results show that after the shikimic acid bacteria residue is used to replace cottonseed protein and corn steep liquor, the cost of spiramycin fermentation formula is greatly reduced.
[0047] Effect Example 2
[0048] The original formula of spiramycin fermentation production was used as the control group, and the fermentation formulas of Examples 1-3 were used as experimental groups 1-3. The quality of the spiramycin products obtained by fermentation was tested, and the results are shown in Table 2.
[0049] Table 2 Comparative test data of spiramycin product quality
[0050]
[0051] It can be seen from Table 2 that the technical solution provided by the present invention has a spiramycin product whose quality is significantly better than that of the existing traditional fermentation formula. Combined with the low cost of fermentation raw materials, the technical solution of the present invention has the beneficial effects of high quality and low price, and has obvious market competitiveness for production enterprises.
[0052] The foregoing description of specific exemplary embodiments of the present invention is for the purpose of illustration and demonstration. These descriptions are not intended to limit the present invention to the precise form disclosed, and it is clear that many changes and variations can be made based on the above teachings. The purpose of selecting and describing the exemplary embodiments is to explain the specific principles of the present invention and its practical application, so that those skilled in the art can realize and utilize various different exemplary embodiments of the present invention and various different selections and changes. The scope of the present invention is intended to be limited by the claims and their equivalents.
Claims
1. A method for producing spiramycin by using shikimic acid fermentation residue, characterized in that: The following steps are involved: 1) preparing shikimic acid fermentation residue: filtering the waste liquid recovered from the production of shikimic acid, collecting the precipitate to obtain shikimic acid fermentation residue; 2) Using the shikimic acid fermentation residue obtained in step 1) as a component of the fermentation medium to replace cottonseed protein and / or corn steep liquor for fermentation production of spiramycin.
2. The method for producing spiramycin by using shikimic acid fermentation residue as claimed in claim 1, characterized in that: In the step 1), a ceramic membrane is used for filtration, and the filtration pore size is 20-50 nm.
3. The method for producing spiramycin by using shikimic acid fermentation residue as claimed in claim 1, characterized in that: In the step 1), the prepared shikimic acid fermentation residue is tested: the total protein is ≥ 50%.
4. The method for producing spiramycin by using shikimic acid fermentation residue as claimed in claim 1, characterized in that: In the step 2), the scheme of replacing cottonseed protein and / or corn steep liquor with shikimic acid fermentation residue specifically includes: replacing 50% of the cottonseed protein and 40% of the corn steep liquor with the same mass of shikimic acid fermentation residue; or, replacing 80% of the cottonseed protein and 50% of the corn steep liquor with the same mass of shikimic acid fermentation residue; or, replacing 100% of the cottonseed protein and 60% of the corn steep liquor with the same mass of shikimic acid fermentation residue.
5. The method for producing spiramycin by using shikimic acid fermentation residue as claimed in claim 1, characterized in that: In step 2), the fermentation medium comprises the following components by weight: 86.4-129.6 parts by weight of dextrin, 2.22-3.32 parts by weight of yeast powder, 2.88-4.32 parts by weight of sodium nitrate, 0-23.06 parts by weight of cottonseed protein, 5.76-8.64 parts by weight of sodium chloride, 4.43-6.65 parts by weight of potassium chloride, 36-54 parts by weight of glucose, and 14.7 parts by weight of calcium carbonate. 6-22.14 weight parts, corn steep liquor 21.60-32.4 weight parts, ammonium sulfate 2.88-4.32 weight parts, soybean oil 21.6-32.4 weight parts, magnesium sulfate 1.47-2.21 weight parts, dapoxetine 0.29-0.43 weight parts, cobalt chloride 0.43-0.65 weight parts, potassium dihydrogen phosphate 5.9-8.86 weight parts, shikimic acid fermentation residue 44.66-78.52 weight parts.
6. The method for producing spiramycin by using shikimic acid fermentation residue as claimed in claim 5, characterized in that: In the step 2), the components of the fermentation medium include the following components in parts by weight: 108 parts by weight of dextrin, 2.77 parts by weight of yeast powder, 3.6 parts by weight of sodium nitrate, 0-23.06 parts by weight of cottonseed protein, 7.2 parts by weight of sodium chloride, 5.54 parts by weight of potassium chloride, 45 parts by weight of glucose, 18.45 parts by weight of calcium carbonate, 21.60-32.4 parts by weight of corn steep liquor, 3.6 parts by weight of ammonium sulfate, 27 parts by weight of soybean oil, 1.85 parts by weight of magnesium sulfate, 0.36 parts by weight of folate, 0.54 parts by weight of cobalt chloride, 7.2 parts by weight of potassium dihydrogen phosphate, and 44.66-78.52 parts by weight of shikimic acid fermentation residue.
7. Spiramycin prepared by the method according to any one of claims 1 to 6.
